Call Us Today @ 0172 - 4680800 | | NSE - BSE
Paracetamol may impair fertility of female offsprings: Study
Although paracetamol is considered safe for mothers-to-be, a study has recently warned that pregnant women should think twice before popping these pills as it may impair the fertility of their female offspring's.

The findings indicated that paracetamol when taken during pregnancy altered the development of the reproductive systems of female offspring's.

Paracetamol, or acetaminophen, is an over-the-counter treatment for pain relief that is commonly taken by pregnant women worldwide.

Study author Dr. David Kristensen and colleagues from Copenhagen University Hospital conducted three individual rodent studies to evaluate the effect of paracetamol taken during pregnancy on the development of the reproductive system in female offspring.

The results indicated that the rodents, who were given paracetamol during pregnancy at doses equivalent to those that of a pregnant woman may take for pain relief, produced female offspring with fewer eggs.

This means that in adulthood, they have fewer eggs available for fertilisation, which may reduce their chances of successful reproduction, particularly as they get older.

Dr Kristensen said, "Although this may not be a severe impairment to fertility, it is still of real concern since data from three different labs all independently found that paracetamol may disrupt female reproductive development in this way, which indicates further investigation is needed to establish how this affects human fertility."

However, establishing a link between paracetamol taken by mothers during pregnancy and fertility problems much later in the adult life of the child will be difficult.

He stated, "As scientists, we are not in the position to make any medical recommendations and we would urge pregnant women in pain to consult with their general practitioner, midwife or pharmacist for professional advice."

The research appears in Endocrine Connections journal.

(Health World)
Other Related News:
FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors
India plans measures to facilitate drug exports
Most Smokers With Head and Neck Cancer Have Tried to Quit
Scientists identify connection between dopamine and behavior related to pain and fear
Digital disruption in clinical trials
INS partners with WCEA to offer high-quality, infusion therapy-related education to nursing professionals around globe
Cipla arm recalls multiple lots of antidepressant drug from US
The collapse of the Venezuelan health system
Ranbaxy's demise wake-up call for business families in India
Corona Remedies acquires two brands from Abbott